aTyr Pharma
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. aTyr Pharma's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 97% to $353,000. Profit margin reached -14275%. Total operating expenses were $52,531,000.

Profit Margin

aTyr Pharma, Inc. (NASDAQ:LIFE): Profit margin
2014 0 -24.35M
2015 0 -47.97M
2016 0 -57.85M
2017 0 -48.20M
2018 0 -34.51M
2019 422K -22.23M -5269.43%
2020 10.45M -14.95M -143.07%
2021 0 -32.46M
2022 10.38M -44.27M -426.31%
2023 353K -50.38M -14274.5%

LIFE Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
353K10.38M010.45M422K00000
Cost of revenue
2.74M1.69M1.30M17.29M14.04M00000
Gross profit
-2.38M8.69M-1.30M-6.83M-13.62M00000
Operating exp.
Research and development
42.29M42.80M23.26M17.29M14.04M20.38M30.06M42.84M34.50M16.77M
Selling and marketing
-2.74M000000000
Total operating expenses
52.53M56.79M34.01M26.36M23.4M32.82M47.14M57.94M47.61M23.55M
Operating income
-54.91M-46.40M-34.01M-15.91M-22.97M-32.82M-47.14M-57.94M-47.61M-23.55M
Other income (expenses), net
4.52M1.06M238K-319K-785K-1.69M-1.06M-29K-357K-796K
Income before tax
-50.39M-45.34M-33.77M-16.23M-23.76M-34.51M-48.20M-57.90M-47.97M-24.35M
Income tax expense
-8K-1.06M-1.31M-1.27M-1.52M-1.69M-713K-49K-869K796K
Net income
-50.38M-44.27M-32.46M-14.95M-22.23M-34.51M-48.20M-57.85M-47.97M-24.35M
Earnings per share
Basic EPS
-0.94-1.56-1.7-1.63-6.63-16.13-26.13-34.2-42.4-33.84
Diluted EPS
-0.94-1.56-1.7-1.63-6.63-16.11-26.13-34.2-42.4-33.84
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source